These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer. Takei H, Suemasu K, Kurosumi M, Horii Y, Ninomiya J, Yoshida M, Hagiwara Y, Inoue K, Tabei T. Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996 [Abstract] [Full Text] [Related]
6. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla? Koukouraki S, Sanidas E, Askoxilakis J, Stathaki M, Charalambakis V, Daboudi M, Voutoufianaki I, Kafousi M, Stathopoulos E, Tsiftsis D, Karkavitsas N. Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472 [Abstract] [Full Text] [Related]
7. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A. J Surg Oncol; 2006 Feb 01; 93(2):109-19. PubMed ID: 16425290 [Abstract] [Full Text] [Related]
9. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study. Reed J, Rosman M, Verbanac KM, Mannie A, Cheng Z, Tafra L. J Am Coll Surg; 2009 Mar 01; 208(3):333-40. PubMed ID: 19317993 [Abstract] [Full Text] [Related]
11. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients? Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, Casà L, Noto A. Chir Ital; 2007 Mar 01; 59(5):693-9. PubMed ID: 18019642 [Abstract] [Full Text] [Related]
13. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years. Groetelaers RP, van Berlo CL, Nijhuis PH, Schapers RF, Gerritsen HA. Eur J Surg Oncol; 2009 Feb 01; 35(2):159-63. PubMed ID: 18789841 [Abstract] [Full Text] [Related]
16. Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging. Vanderveen KA, Schneider PD, Khatri VP, Goodnight JE, Bold RJ. Ann Surg Oncol; 2006 Nov 01; 13(11):1450-6. PubMed ID: 17009150 [Abstract] [Full Text] [Related]
17. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients. Langer I, Guller U, Hsu-Schmitz SF, Ladewig A, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M. Eur J Surg Oncol; 2009 Aug 01; 35(8):805-13. PubMed ID: 19046846 [Abstract] [Full Text] [Related]
18. Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes. Bonneau C, Hequet D, Estevez JP, Pouget N, Rouzier R. Eur J Surg Oncol; 2015 Aug 01; 41(8):998-1004. PubMed ID: 25986854 [Abstract] [Full Text] [Related]
20. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure. Montagna E, Viale G, Rotmensz N, Maisonneuve P, Galimberti V, Luini A, Intra M, Veronesi P, Mazzarol G, Pruneri G, Renne G, Torrisi R, Cardillo A, Cancello G, Goldhirsch A, Colleoni M. Breast Cancer Res Treat; 2009 Nov 01; 118(2):385-94. PubMed ID: 19562480 [Abstract] [Full Text] [Related] Page: [Next] [New Search]